North America Biopsy Devices Market Forecast 2024-2032
KEY FINDINGS
The North America biopsy devices market is anticipated to prosper at a CAGR of 7.59% over the forecast period of 2024-2032. The market growth is escalated by several factors, including the rising prevalence of cancer, increasing demand for minimally invasive surgeries, and a surge in the number of hospitals and diagnostic centers.
MARKET INSIGHTS
The North America biopsy devices market is experiencing developing growth driven by advancements in healthcare technology and an increasing focus on early disease detection. Biopsy devices are instrumental in obtaining tissue samples for diagnostic purposes, aiding in the identification and characterization of various medical conditions, particularly cancer. The prevalence of cancer and other chronic diseases, coupled with a growing aging population, has led to a surge in demand for biopsy procedures in the region. The market features a diverse range of biopsy devices, including needle-based instruments, core biopsy devices, and vacuum-assisted biopsy systems.
Additionally, technological innovations, such as minimally invasive biopsy techniques and advanced imaging guidance systems, are contributing to the market's expansion. The market reflects an evolving field with the integration of modern technologies for more precise and efficient biopsy procedures. Government initiatives supporting cancer screening programs and advancements like the incorporation of artificial intelligence in diagnostics further propel market growth. Ongoing research and technological advancements are anticipated to shape the future of this critical healthcare sector, ensuring its role in providing essential diagnostic solutions in the evolving healthcare sphere of North America. As a result, these factors are set to boost the market’s growth in North America during the forecast period.
COMPETITIVE INSIGHTS
Some of the major companies in the North America biopsy devices market include Inrad Inc, DTR Medical, Cardinal Health, Boston Scientific, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Methodology
- 1.3. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 2.3. Scope Of Study
- 2.4. Crisis Scenario Analysis
- 2.4.1. Impact Of Covid-19 On Biopsy Devices Market
- 2.5. Major Market Findings
- 2.5.1. Growing Emphasis On Personalized Medicine
- 2.5.2. Expanding Applications Across Medical Specialities
- 2.5.3. Development Of Cost-effective Biopsy Solutions
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Rising Prevalence Of Cancer
- 3.1.2. Increasing Demand For Minimally Invasive Surgeries
- 3.1.3. Surge In The Number Of Hospitals And Diagnostic Centers
- 3.2. Key Restraints
- 3.2.1. High Risk Of Infection For Patients
- 3.2.2. High Cost Of Biopsy Procedures
- 3.2.3. Lack Of Skilled Professionals
- 4. Key Analytics
- 4.1. Key Market Trends
- 4.1.1. Surge In The Healthcare Expenditure
- 4.1.2. Shift Towards Preventive Healthcare
- 4.1.3. Advancements In Biopsy Technology
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Buyers Power
- 4.2.2. Suppliers' Power
- 4.2.3. Substitutions
- 4.2.4. New Entrants
- 4.2.5. Industry Rivalry
- 4.3. Growth Prospect Mapping
- 4.4. Value Chain Analysis
- 4.4.1. Raw Materials
- 4.4.2. Manufacturers
- 4.4.3. Distribution
- 4.4.4. End-users
- 5. Market By Product
- 5.1. Needle- Based Biopsy Guns
- 5.1.1. Vacuum-assisted Biopsy (Vab) Devices
- 5.1.2. Fine Needle Aspiration Biopsy (Fnab) Devices
- 5.1.3. Core Needle Biopsy (Cnb) Devices
- 5.2. Biopsy Guidance Systems
- 5.3. Biopsy Needles
- 5.4. Biopsy Forceps
- 5.5. Other Products
- 6. Market By Application
- 6.1. Oncology
- 6.2. Gastroenterology
- 6.3. Pulmonology
- 6.4. Dermatology
- 6.5. Other Applications
- 7. Market By End Use
- 7.1. Hospitals
- 7.2. Ambulatory Surgical Centers
- 7.3. Diagnostic Centers
- 8. Geographical Analysis
- 8.1. North America
- 8.1.1. Market Size & Estimates
- 8.1.2. North America Biopsy Devices Market Drivers
- 8.1.3. North America Biopsy Devices Market Challenges
- 8.1.4. Key Players In North America Biopsy Devices Market
- 8.1.5. Country Analysis
- 8.1.5.1. United States
- 8.1.5.2. Canada
- 9. Competitive Landscape
- 9.1. Key Strategic Developments
- 9.1.1. Mergers & Acquisitions
- 9.1.2. Product Launches & Developments
- 9.1.3. Partnerships & Agreements
- 9.1.4. Business Expansions & Divestitures
- 9.2. Company Profiles
- 9.2.1. Cardinal Health
- 9.2.2. Hologic Inc
- 9.2.3. Danaher Corporation
- 9.2.4. Conmed Corporation
- 9.2.5. Cook Medical
- 9.2.6. Dtr Medical
- 9.2.7. Inrad Inc
- 9.2.8. Boston Scientific
- 9.2.9. Medtronic Plc
- 9.2.10. Becton Dickinson And Company
- 9.2.11. Mammotome
- 9.2.12. Argon Medical Devices
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook